[ad_1] The company said its RSV vaccine was 83.7% effective against lower-respiratory diseases caused by RSV in the study. [ad_2] Source link
Tag: New Product/Service Testing
Why Biotech Is Poised for a Recovery This Year
[ad_1] Markets Heard on the Street Pharma and biotech stocks moved in opposite directions last year, but fortunes are shifting [ad_2] Source link
FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs
[ad_1] Health Agency places more holds on trials to protect patients, ensure studies are designed properly, Wall Street Journal review finds [ad_2] Source link
AstraZeneca to Buy U.S. Cardiorenal-Drug Maker
[ad_1] For an initial $1.3 billion, the Anglo-Swedish company will acquire CinCor Pharma, including rights to its baxdrostat cardiorenal drug, which has shown promise in clinical trials. [ad_2] Source link
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
[ad_1] Health Medicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy [ad_2] Source link
China’s New mRNA Covid Vaccine Targeting Omicron Starts Trial Production
[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link
China to Allow Rapid Tests to Confirm Covid Cases
[ad_1] World Asia China Beijing takes more steps to dismantle its zero-Covid policies [ad_2] Source link
China-Developed mRNA Covid Vaccine Starts Test Production
[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link
Two Biotech CEOs Indicted on Securities Fraud Charges
[ad_1] The former chief executive of CytoDyn and the CEO of a company that managed its clinical trials allegedly made fraudulent claims about an experimental drug. [ad_2] Source link
Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study
[ad_1] Business Health Care Health The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said [ad_2] Source link